SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
CT ORDER

CT ORDER

Other
View HTML
S-3

Simplified registration form

Registration Statements
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe